(Q45840153)

English

High-fat and fructose intake induces insulin resistance, dyslipidemia, and liver steatosis and alters in vivo macrophage-to-feces reverse cholesterol transport in hamsters

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22357742

High-fat and fructose intake induces insulin resistance, dyslipidemia, and liver steatosis and alters in vivo macrophage-to-feces reverse cholesterol transport in hamsters (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22357742

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

François Briand

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22357742

Quentin Thiéblemont

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22357742

Elodie Muzotte

3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22357742

Thierry Sulpice

4

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22357742

language of work or name

0 references

publication date

22 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22357742

Journal of Nutrition

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22357742

142

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22357742

4

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22357742

704-709

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22357742

Metabolic effects of fructose and the worldwide increase in obesity.

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Cardiovascular outcomes in type 2 diabetes: the impact of preventative therapies.

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Diet-induced dyslipidemia impairs reverse cholesterol transport in hamsters

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Role of intestinal sterol transporters Abcg5, Abcg8, and Npc1l1 in cholesterol absorption in mice: gender and age effects

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

An adiponectin-like molecule with antidiabetic properties.

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Dietary copper: cholesterol and lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Is there any progress in the treatment of non-alcoholic fatty liver disease?

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Metabolic disturbances in non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Mechanisms by which saturated triacylglycerols elevate the plasma low density lipoprotein-cholesterol concentration in hamsters. Differential effects of fatty acid chain length

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

ABCG5 and ABCG8 Are Obligate Heterodimers for Protein Trafficking and Biliary Cholesterol Excretion

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Reverse cholesterol transport revisited: contribution of biliary versus intestinal cholesterol excretion

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Regulation of direct transintestinal cholesterol excretion in mice

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit

1 reference

https://api.crossref.org/works/10.3945%2FJN.111.153197

21 January 2018

Identifiers

10.3945/JN.111.153197

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22357742

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/22357742

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45840153&oldid=2085280127"